It has been discovered that personalized dosing in the treatment of prostate cancer improves patient outcomes.

Published Date: 28 Jun 2023

Physicians can personalize dosing intervals and significantly enhance patient outcomes by tracking early-response biomarkers in men receiving 177Lu-PSMA prostate cancer therapy.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Ultrasound imaging of breast cancer tumors offers noninvasive monitoring of treatment effectiveness

2.

Cancerous breast tissue glows in new AI-enhanced MRI images

3.

Scholastic performance is a key concern for young cancer patients, study finds

4.

A smartphone app enhances the tracking of recovery following breast and gynecologic oncology surgery, according to JAMA.

5.

Researchers identify a novel biomarker linked to renal cancer recurrence


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot